Scared of needles? AstraZeneca launches FluMist Home nasal spray delivery

AstraZeneca introduces FluMist Home, offering a needle-free flu vaccine delivered directly to your door. This FDA-approved nasal spray allows adults aged 18-49 and parents of children aged 2-17 to administer the vaccine at home, bypassing doctor's visits.

Top Stories